Literature DB >> 7003717

Multiple primary cancers in Hodgkin's disease.

R S Brody, D Schottenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003717

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Malignant lymphoma of the conjunctiva following Hodgkin's disease.

Authors:  H E Grossniklaus; D C Farhi; B R Jacobson; M F Abbuhl
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

2.  Case report 409: Non-Hodgkin lymphoma (diffuse histiocytic or malignant lymphoma, diffuse, large cell B-cell immunophenotype).

Authors:  T S Samuels; B A Howard; J D Rubenstein; J Srigley
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

3.  Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.

Authors:  S Shikuwa; M Ito; M Nakashima; K Hamasaki; S Naito; I Sekine; H Fujii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

4.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

5.  [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors:  W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal:  Klin Wochenschr       Date:  1981-03-16

6.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

7.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

8.  Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study.

Authors:  M P Coleman; C M Bell; P Fraser
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.